DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Eimco Elecon (India) Limited — Product launch (Sub-para 3-Para B)

NSE 49 min ago·30 Oct 2026, 9:17 am

Eimco Elecon (India)

Eimco Elecon (India) has announced a new product launch, which is expected to diversify its offerings and potentially broaden its market reach. This development signals the company's ongoing efforts to expand its portfolio and strengthen its competitive position in the industry.

For investors, this news is significant as it highlights the company's growth strategy and its ability to innovate. A successful product launch can lead to increased sales and revenue, which may positively impact the stock's performance in the long run.

Investors should monitor the market reception of the new product and the company's subsequent financial disclosures. Tracking sales figures and customer feedback will be crucial to understanding the long-term impact of this launch on the business.